Our top pick for
Rockwell Medical, Inc is a drug manufacturers—specialty & generic business based in the US. Rockwell Medical shares (RMTI) are listed on the NASDAQ and all prices are listed in US Dollars. Rockwell Medical employs 299 staff and has a trailing 12-month revenue of around USD$62.5 million.
|Latest market close||USD$1.19|
|52-week range||USD$0.83 - USD$3.85|
|50-day moving average||USD$0.974|
|200-day moving average||USD$1.5318|
|Wall St. target price||USD$7|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.595|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||11.21%|
|1 month (2020-12-15)||9.17%|
|3 months (2020-10-15)||9.17%|
|6 months (2020-07-15)||-35.33%|
|1 year (2020-01-15)||-57.35%|
|2 years (2019-01-15)||-60.33%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-15)||7.36|
|Revenue TTM||USD$62.5 million|
|Gross profit TTM||USD$2.8 million|
|Return on assets TTM||-26.02%|
|Return on equity TTM||-89.78%|
|Market capitalisation||USD$98.3 million|
TTM: trailing 12 months
There are currently 3.1 million Rockwell Medical shares held short by investors – that's known as Rockwell Medical's "short interest". This figure is 21.7% down from 3.9 million last month.
There are a few different ways that this level of interest in shorting Rockwell Medical shares can be evaluated.
Rockwell Medical's "short interest ratio" (SIR) is the quantity of Rockwell Medical shares currently shorted divided by the average quantity of Rockwell Medical shares traded daily (recently around 1.2 million). Rockwell Medical's SIR currently stands at 2.56. In other words for every 100,000 Rockwell Medical shares traded daily on the market, roughly 2560 shares are currently held short.
However Rockwell Medical's short interest can also be evaluated against the total number of Rockwell Medical shares, or, against the total number of tradable Rockwell Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Rockwell Medical's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Rockwell Medical shares in existence, roughly 30 shares are currently held short) or 0.0304% of the tradable shares (for every 100,000 tradable Rockwell Medical shares, roughly 30 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Rockwell Medical.
Find out more about how you can short Rockwell Medical stock.
We're not expecting Rockwell Medical to pay a dividend over the next 12 months.
Over the last 12 months, Rockwell Medical's shares have ranged in value from as little as $0.83 up to $3.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rockwell Medical's is 0.9955. This would suggest that Rockwell Medical's shares are less volatile than average (for this exchange).
Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.